The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA axis disturbance preceding relapse (Appelhof et al. 2006; Aubry et al. 2007; Holsboer et al. 1982; Zobel et al. 2001)”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Aubry et al. 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672 · cited 2×
“One domain of investigation that has generated a lot of interest is the role of the hypothalamo–pituitary–adrenocortical (HPA) axis in the pathophysiology of mood disorders (Holsboer, 1995; Plotsky et al., 1998), particularly dysfunctioning of”
BackgroundThe combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana, G. W. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790350067012 · Cited by 526
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs
Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., & Russell, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1102 · Cited by 386
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.03.007 · Cited by 229 · cited 1×
“Regarding this last point, it is important to underline that we included patients considered in clinical remission, that is with a MADRS score 68, which corresponds to a Hamilton rating scale for depression (HSRD) 65 (Zimmerman et al., 2004).”
BackgroundHolsboer, F., von Bardeleben, U., Wiedemann, K., Müller, O. A., & Stalla, G. K. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90237-x · Cited by 221 · cited 2×
“to enhance ACTH and cortisol responses (Holsboer et al., 1987; von Bardeleben and Holsboer, 1989).”
MethodCorticosteroid Receptor Function Is Decreased in Depressed Patients
Modell, S., Yassouridis, A., Huber, J., & Holsboer, F. (2008) · Neuroendocrinology · doi:10.1159/000127275 · Cited by 204
Kunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200
Research works printed but not linked: 9
- Coppen, 1983, Dexamethasone suppression test in depression and other psychiatric illness, British Journal of Psychiatry, 142, 498, 10.1192/bjp.142.5.498 · DOI · Paper page
- Hatzinger, 2002, The combined DEX–CRH test in treatment course and long-term outcome of major depression, Journal of Psychiatric Research, 36, 287, 10.1016/S0022-3956(02)00021-3 · DOI
- Ising, 2005, The combined dexamethasone/CRH test as a potential surrogate marker in depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29, 1085, 10.1016/j.pnpbp.2005.03.014 · DOI · Paper page
- Kunzel, 2003, Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the DEX–CRH test, Neuropsychopharmacology, 28, 2169, 10.1038/sj.npp.1300280 · DOI · Paper page
- Oshima, 2000, The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders, Journal of Psychiatric Research, 34, 325, 10.1016/S0022-3956(00)00021-2 · DOI
- Oshima, 2001, Psychological, autonomic and neuroendocrine responses to acute stressors in the combined dexamethasone/CRH test: a study in healthy subjects, Journal of Psychiatric Research, 35, 95, 10.1016/S0022-3956(01)00010-3 · DOI
- Sheehan, 1998, The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, Journal of Clinical Psychiatry, 59, 22
- von Bardeleben, 1991, Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone, Biological Psychiatry, 29, 1042, 10.1016/0006-3223(91)90360-X · DOI
- Zobel, 1999, Prediction of medium-term outcome by cortisol response to the combined dexamethasone–CRH test in patients with remitted depression, American Journal of Psychiatry, 156, 949, 10.1176/ajp.156.6.949 · DOI · Paper page
Cited by
Decision making under stress: A selective review
Starcke, K., & Brand, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.003 · Cited by 870
Prospective biomarkers of major depressive disorder: A systematic review and meta-analysis
Kennis, M., Gerritsen, L., van Dalen, M., Williams, A., Cuijpers, P., & Bockting, C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0585-z · Cited by 435
Joëls, M., Sarabdjitsingh, R. A., & Karst, H. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005892 · Cited by 425
Zimmermann, P., Brückl, T., Nocon, A., Pfister, H., Binder, E. B., Uhr, M., Lieb, R., Moffitt, T. E., Caspi, A., Holsboer, F., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111577 · Cited by 262
“Since hypercortisolism due to an impaired regulation of the HPA axis can be regarded as a prominent feature of depression (3, 43, 44), our result (elevated risk of major depressive episodes in trauma-exposed homozygous minor allele carriers) can be explained by direct effects of the investigated genotypes on FKBP5 exp…”
BackgroundWeiser, M. J., & Handa, R. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.058 · Cited by 250
“Furthermore, the DEX/CRH test has been used to accurately predict relapse and can be used as a biomarker to positively identify novel treatments for depression (Aubry et al., 2007; Ising et al., 2007).”
Metadata
- Authors
- Aubry, J.-M., Gervasoni, N., Osiek, C., Perret, G., Rossier, M. F., Bertschy, G., & Bondolfi, G.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 41
- Issue
- 3-4
- Pages
- 290-294
- ISSN
- 0022-3956
- Cited by
- 58
- References
- 13
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. https://app.cochat.ai/papers/10.1016/j.jpsychires.2006.07.007
- The paper
- Aubry, J.-M., Gervasoni, N., Osiek, C., Perret, G., Rossier, M. F., Bertschy, G., & Bondolfi, G. (2007). The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2006.07.007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.